<DOC>
	<DOCNO>NCT00534456</DOCNO>
	<brief_summary>The purpose Study 20060172 measure echocardiographic parameter biomarkers subgroup study subject enrol Study 20050222 ( RED-HF Trial ) . This substudy 20060172 terminate early due feasibility constraint . All subject enrol 20060172 also enrol Study 20050222 , ongoing . Study data analyze Study 20050222 end , since unblinding would adversely affect Study 20050222 .</brief_summary>
	<brief_title>An Exploratory Sub-study RED-HFâ„¢ ( Reduction Events With Darbepoetin Alfa Heart Failure ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Signed informed consent Study 20060172 Randomized Study 20050222 Any condition situation , investigator 's opinion , may put subject significant risk , render subject unsuitable accurate echocardiography , may confound study result , may interfere significantly subject 's participation Study 20060172 Study 20050222 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>exploratory study</keyword>
	<keyword>anemia</keyword>
	<keyword>pharmacogenetics test</keyword>
	<keyword>biomarkers</keyword>
	<keyword>echocardiography</keyword>
</DOC>